Yingchao Wang

6.2k total citations
148 papers, 3.7k citations indexed

About

Yingchao Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yingchao Wang has authored 148 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 44 papers in Cancer Research and 23 papers in Oncology. Recurrent topics in Yingchao Wang's work include Cancer-related molecular mechanisms research (27 papers), RNA modifications and cancer (18 papers) and MicroRNA in disease regulation (14 papers). Yingchao Wang is often cited by papers focused on Cancer-related molecular mechanisms research (27 papers), RNA modifications and cancer (18 papers) and MicroRNA in disease regulation (14 papers). Yingchao Wang collaborates with scholars based in China, United States and Switzerland. Yingchao Wang's co-authors include Jing‐Yuan Fang, Jie Hong, Jilin Wang, Xiaolong Liu, Yì Wáng, Xinyang Hu, Jingfeng Liu, Wan Du, Bixing Zhao and Jinghai Chen and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Yingchao Wang

130 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingchao Wang China 32 2.3k 1.4k 588 487 375 148 3.7k
You Mie Lee South Korea 40 3.4k 1.5× 1.5k 1.1× 777 1.3× 279 0.6× 506 1.3× 119 5.0k
Qian Zhao China 31 2.4k 1.0× 1.6k 1.2× 450 0.8× 226 0.5× 264 0.7× 110 3.4k
Hongmei Li China 35 2.6k 1.1× 937 0.7× 841 1.4× 283 0.6× 751 2.0× 165 4.7k
Liang Zhao China 38 2.4k 1.0× 1.4k 1.0× 709 1.2× 303 0.6× 402 1.1× 166 3.7k
Marie C. Lin China 34 2.5k 1.1× 1.8k 1.3× 603 1.0× 333 0.7× 257 0.7× 56 3.7k
Alexander T.H. Wu Taiwan 40 2.6k 1.1× 1.1k 0.8× 1.1k 1.9× 529 1.1× 484 1.3× 170 5.1k
Yangfu Jiang China 31 2.7k 1.2× 1.2k 0.9× 1.1k 1.9× 336 0.7× 525 1.4× 70 4.9k
Yingjie Zhang China 38 2.6k 1.1× 730 0.5× 811 1.4× 206 0.4× 292 0.8× 194 4.1k
Jin Hyen Baek United States 31 2.9k 1.3× 1.3k 0.9× 600 1.0× 249 0.5× 221 0.6× 74 4.4k
Yun‐Yong Park South Korea 34 2.2k 0.9× 827 0.6× 844 1.4× 425 0.9× 341 0.9× 71 3.5k

Countries citing papers authored by Yingchao Wang

Since Specialization
Citations

This map shows the geographic impact of Yingchao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingchao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingchao Wang more than expected).

Fields of papers citing papers by Yingchao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingchao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingchao Wang. The network helps show where Yingchao Wang may publish in the future.

Co-authorship network of co-authors of Yingchao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yingchao Wang. A scholar is included among the top collaborators of Yingchao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingchao Wang. Yingchao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Bin, Guobing Xu, Bixing Zhao, et al.. (2025). Hypoxia-induced exosomal LUCAT1 promotes osimertinib resistance in lung adenocarcinoma by stabilizing c-MET. Cell Death and Disease. 16(1). 763–763.
2.
Yang, Zhou, et al.. (2024). Avapritinib efficacy in primary hepatic neuroendocrine carcinoma with elevated PDGFRA expression: Insights from a PDX model study. Biochemical and Biophysical Research Communications. 736. 150504–150504. 1 indexed citations
3.
Dong, Jing, Ruixue Song, Yingchao Wang, et al.. (2024). Identification of important modules and biomarkers in tuberculosis based on WGCNA. Frontiers in Microbiology. 15. 1354190–1354190. 2 indexed citations
4.
5.
Zhuang, Qiuyu, Xuechun Xu, Youshi Zheng, et al.. (2023). RNA Methyltransferase FTSJ3 Regulates the Type I Interferon Pathway to Promote Hepatocellular Carcinoma Immune Evasion. Cancer Research. 84(3). 405–418. 11 indexed citations
6.
7.
Wu, Ming, Hao Li, Zhang Cao, et al.. (2023). Silk‐Gel Powered Adenoviral Vector Enables Robust Genome Editing of PD‐L1 to Augment Immunotherapy across Multiple Tumor Models. Advanced Science. 10(12). e2206399–e2206399. 20 indexed citations
8.
Liu, Xinran, Zhongli Wang, Lu Jiang, et al.. (2023). Copper Phthalocyanine Improving Nonaqueous Catalysis of Pseudomonas cepacia Lipase for Ester Synthesis. Applied Biochemistry and Biotechnology. 196(4). 1786–1802. 2 indexed citations
9.
Song, You, et al.. (2023). Hsa_circ_0001687 Function as a ceRNA to Facilitate HepatocellularCarcinoma Progression via miR-140- 3p/FOXQ1 Axis. Protein and Peptide Letters. 30(11). 930–940.
10.
Wang, Yingchao, Yong Yang, Yuan Dang, et al.. (2023). Hypoxia induces hepatocellular carcinoma metastasis via the HIF-1α/METTL16/lnc-CSMD1-7/RBFOX2 axis. iScience. 26(12). 108495–108495. 20 indexed citations
11.
Li, Jiaming, et al.. (2023). Scaffold Hybrid of the Natural Product Tanshinone I with Piperidine for the Discovery of a Potent NLRP3 Inflammasome Inhibitor. Journal of Medicinal Chemistry. 66(4). 2946–2963. 21 indexed citations
12.
Wang, Yingchao, et al.. (2023). Tripterygium wilfordii Hook. F. and Its Extracts for Psoriasis: Efficacy and Mechanism. Drug Design Development and Therapy. Volume 17. 3767–3781. 13 indexed citations
13.
Liu, Ningning, Hao Liu, Junhua Zhang, et al.. (2020). High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3. Phytomedicine. 68. 153171–153171. 19 indexed citations
14.
Gao, Feng, Masaharu Kataoka, Ning Liu, et al.. (2019). Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarction. Nature Communications. 10(1). 1802–1802. 212 indexed citations
15.
Ke, Kun, Geng Chen, Zhixiong Cai, et al.. (2018). Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification. Cancer Management and Research. Volume 10. 5291–5302. 19 indexed citations
16.
Liu, Fangchao, et al.. (2018). A novel gene mutation in maturity-onset diabetes of the young (MODY-11): Case report. Zhonghua neifenmi daixie zazhi. 34(8). 696–698.
17.
Zheng, Youshi, Yingchao Wang, Zhixiong Cai, et al.. (2018). Co-culture system of hepatocytes and endothelial cells: two in vitro approaches for enhancing liver-specific functions of hepatocytes. Cytotechnology. 70(4). 1279–1290. 13 indexed citations
18.
Hu, Ye, Jilin Wang, Jin Qian, et al.. (2014). Long Noncoding RNA GAPLINC Regulates CD44-Dependent Cell Invasiveness and Associates with Poor Prognosis of Gastric Cancer. Cancer Research. 74(23). 6890–6902. 231 indexed citations
19.
Zhang, Yufeng, et al.. (2012). A new flavan-3-ol lactone and other constituents from Euonymus alatus with inhibitory activities on α-glucosidase and differentiation of 3T3-L1 cells. Natural Product Research. 27(17). 1513–1520. 10 indexed citations
20.
Wang, Yingchao. (2011). Soxhlet Extraction of Belveder Fruit Oil. Shipin yanjiu yu kaifa. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by You Mie Lee Breakdown of academic impact, for papers by Qian Zhao Breakdown of academic impact, for papers by Hongmei Li Breakdown of academic impact, for papers by Liang Zhao Breakdown of academic impact, for papers by Marie C. Lin Breakdown of academic impact, for papers by Alexander T.H. Wu Breakdown of academic impact, for papers by Yangfu Jiang Breakdown of academic impact, for papers by Yingjie Zhang Breakdown of academic impact, for papers by Jin Hyen Baek Breakdown of academic impact, for papers by Yun‐Yong Park
Rankless by CCL
2026